Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients-Reference-Cited by-同舟云学术

Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients

Published:2011-10-05 Issue:10 Volume:118 Page:2603-2614
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Jung Eun-Jung,Santarpia Libero,Kim Juyeon,Esteva Francisco J.,Moretti Erica,Buzdar Aman U.,Di Leo Angelo,Le Xiao-Feng,Bast Robert C.,Park Soon-Tae,Pusztai Lajos,Calin George A.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference38 articles.

1. Elevated serum Her-2/neu level predicts decreased response to hormone therapy in metastatic breast cancer;Lipton;J Clin Oncol,2002

2. New strategies in HER2-overexpressing breast cancer: many combinations of targeted drugs available;Abramson;Clin Cancer Res,2011

3. Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease;Cobleigh;J Clin Oncol,1999

4. Weekly trastuzumab and paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER2 immunophenotype and gene amplification;Seidman;J Clin Oncol,2001

5. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2;Slamon;N Engl J Med,2001

Cited by 252 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum miRNA-1 may serve as a promising noninvasive biomarker for predicting treatment response in breast cancer patients receiving neoadjuvant chemotherapy;BMC Cancer;2024-07-02

2. Role and predictive value of microRNAs 204 and 210 in the diagnosis of pulmonary arterial hypertension and the distinction between idiopathic, systemic sclerosis, and schistosomiasis-associated pulmonary arterial hypertension;The Egyptian Journal of Bronchology;2024-06-01

3. Mechanism of miR-126 Loaded in Albumin Nanoparticles for Reversing the Multidrug Resistance in Breast Carcinoma Cells;Journal of Biomedical Nanotechnology;2024-06-01

4. MicroRNAs as promising biomarkers and potential therapeutic agents in breast cancer management: a comprehensive review;Annals of Medicine & Surgery;2024-04-22

5. Functions of Differentially Regulated miRNAs in Breast Cancer Progression: Potential Markers for Early Detection and Candidates for Therapy;Biomedicines;2024-03-20